Eikon Therapeutics Stock
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Sign up today and learn more about Eikon Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Eikon Therapeutics Stock
Eikon Therapeutics is a biopharmaceutical company employing revolutionary technology at the interface of biology, engineering, and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes that enable real-time, molecular-resolution measurements of protein movement in living cells.
Funding History
| May 2021 | $148M |
|---|
Management
Co-Founder
Luke Lavi
Co-Founder
Xavier Darzacq
CEO
Roger Perlmutter
Board Member
Dror Berman
Scientific Advisory Board Member
Larry Lasky
Scientific Advisory Board Member
Eric Schmidt
Scientific Advisory Board Member
Eric Betzig
Scientific Advisory Board Member
Robert Tjian
Scientific Advisory Board Member
Tom Cech
Scientific Advisory Board Member
Juan Jaen
Scientific Advisory Board Member
Fei-Fei Li
Press
biospace - Apr, 5 2024
Director, Financial Planning & Analysis (FP&A) - R&D job with Eikon Therapeutics | 2871325biospace - Apr, 5 2024
Associate Director, Data Management job with Eikon Therapeutics | 2887780biospace - Apr, 5 2024
Manager, Study Start Up job with Eikon Therapeutics | 2886695biospace - Apr, 5 2024
Clinical Trial Associate, Oncology job with Eikon Therapeutics | 2886194EquityZen Recognized As:
